Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages

  Simpson, Daniel R ^a   Song, William Y ^a   Moiseenko, Vitali ^b   Rose, Brent S ^a   Yashar, Catheryn M ^a   Mundt, Arno J ^a   Mell, Loren K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Vancouver Cancer Centre   (Canada)

Author keywords

Cervical cancer; Chemoradiation; Gastrointestinal toxicity; IMRT; NTCP

Indexed keywords

CERVICAL CANCERS; CHEMORADIATION; GASTROINTESTINAL TOXICITIES; IMRT; NTCP;

CHEMOTHERAPY; LOGISTICS; PARAMETER ESTIMATION; PHYSICAL THERAPY; PLATINUM COMPOUNDS; RADIOTHERAPY; TISSUE;

TOXICITY;

CISPLATIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DIARRHEA; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MULTIPLE CYCLE TREATMENT; PERITONEAL CAVITY; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RATING SCALE; RECTUM HEMORRHAGE; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MIDDLE AGED; ORGANS AT RISK; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84859825103     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.012     Document Type: Article

References (20)

1. W.A. Peters 3rd, P.Y. Liu, and R.J. Barrett 2nd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
2. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
3. V. Nagy, N. Todor, and O. Coza Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens J BUON 12 2007 389 394
4. A. Duenas-Gonzalez, J.J. Zarba, and F. Patel Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 2011 1678 1685
5. E.K. Nugent, A.S. Case, and J.T. Hoff Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors Gynecol Oncol 116 2010 438 441
6. A.J. Mundt, A.E. Lujan, and J. Rotmensch Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 2002 1330 1337
7. M.F. Chen, C.J. Tseng, and C.C. Tseng Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients Cancer J 14 2008 200 206
8. M.D. Hasselle, B.S. Rose, and J.D. Kochanski Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix Int J Radiat Oncol Biol Phys 80 2010 1436 1445
9. A. Jhingran, K. Winter, and L. Portelance A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvic for Post-operative Patients with Endometrial Carcinoma (RTOG 0418) Int J Radiat Oncol Biol Phys 72 2008 S16 S17
10. B.D. Minsky, J.A. Conti, and Y. Huang Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer J Clin Oncol 13 1995 1409 1416
11. K. Devisetty, L.K. Mell, and J.K. Salama A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy Radiother Oncol 93 2009 298 301
12. L.M. Tho, M. Glegg, and J. Paterson Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning Int J Radiat Oncol Biol Phys 66 2006 505 513
13. J.M. Robertson, D. Lockman, and D. Yan The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418
14. L. Perna, F. Alongi, and C. Fiorino Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy Radiother Oncol 97 2010 71 75
15. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
16. E.Y. Huang, C.C. Sung, and S.F. Ko The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: A prospective study with computed tomography-based dosimetry Int J Radiat Oncol Biol Phys 69 2007 732 739
17. B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 2010 S101 107
18. RTOG. http://www.rtog.org/ResearchAssociates/AdverseEventReporting/ AcuteRadiationMorbidityScoringCriteria.aspx. Accessed March 23, 2012.
19. R. Mittelhammer The method of maximum likelihood in mathematical statistics for economics and business 1996 Springer New York
20. L.C. Lutgens, N. Deutz, and M. Granzier-Peeters Plasma citrulline concentration: A surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients Int J Radiat Oncol Biol Phys 60 2004 275 285